Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Schomaker

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
American Journal of Epidemiology|March 29, 2020
The Impact of Delayed Switch to Second-Line Antiretroviral Therapy on Mortality, Depending on Definition of Failure Time and CD4 Count at FailureHelen Bell-Gorrod, Matthew P Fox, Andrew Boulle, et al.
Medicine|March 6, 2016
Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral TherapySumanth Karamchand, Rory Leisegang, Michael Schomaker, et al.
Tropical Medicine & International Health : TM & IH|April 3, 2019
Programmatic outcomes and impact of rapid public sector antiretroviral therapy expansion in adults prior to introduction of the WHO treat-all approach in rural EswatiniBernhard Kerschberger, Michael Schomaker, Iza Ciglenecki, et al.
Journal of Virology|May 11, 2012
Refined identification of neutralization-resistant HIV-1 CRF02_AG virusesRajesh Abraham Jacob, Fatima Abrahams, Marcel Tongo, et al.
Frontiers in Immunology|October 26, 2018
Schistosomiasis Burden and Its Association With Lower Measles Vaccine Responses in School Children From Rural CameroonJustin Komguep Nono, Severin Donald Kamdem, Palmer Masumbe Netongo, et al.
American Journal of Epidemiology|November 17, 2014
Do increasing rates of loss to follow-up in antiretroviral treatment programs imply deteriorating patient retention?Leigh F Johnson, Janne Estill, Olivia Keiser, et al.
Plos One|January 13, 2012
Baseline predictors of sputum culture conversion in pulmonary tuberculosis: importance of cavities, smoking, time to detection and W-Beijing genotypeMarianne E Visser, Michael C Stead, Gerhard Walzl, et al.
Plos Medicine|November 8, 2017
Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort studySamantha R Kaplan, Christa Oosthuizen, Kathryn Stinson, et al.
Journal of the International AIDS Society|October 25, 2019
Feasibility of antiretroviral therapy initiation under the treat-all policy under routine conditions: a prospective cohort study from EswatiniBernhard Kerschberger, Kiran Jobanputra, Michael Schomaker, et al.
Journal of Epidemiology and Community Health|December 25, 2015
CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort studyAnna Grimsrud, Morna Cornell, Michael Schomaker, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
American Journal of Epidemiology|March 29, 2020
The Impact of Delayed Switch to Second-Line Antiretroviral Therapy on Mortality, Depending on Definition of Failure Time and CD4 Count at FailureHelen Bell-Gorrod, Matthew P Fox, Andrew Boulle, et al.
Medicine|March 6, 2016
Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral TherapySumanth Karamchand, Rory Leisegang, Michael Schomaker, et al.
Tropical Medicine & International Health : TM & IH|April 3, 2019
Programmatic outcomes and impact of rapid public sector antiretroviral therapy expansion in adults prior to introduction of the WHO treat-all approach in rural EswatiniBernhard Kerschberger, Michael Schomaker, Iza Ciglenecki, et al.
Journal of Virology|May 11, 2012
Refined identification of neutralization-resistant HIV-1 CRF02_AG virusesRajesh Abraham Jacob, Fatima Abrahams, Marcel Tongo, et al.
Frontiers in Immunology|October 26, 2018
Schistosomiasis Burden and Its Association With Lower Measles Vaccine Responses in School Children From Rural CameroonJustin Komguep Nono, Severin Donald Kamdem, Palmer Masumbe Netongo, et al.
American Journal of Epidemiology|November 17, 2014
Do increasing rates of loss to follow-up in antiretroviral treatment programs imply deteriorating patient retention?Leigh F Johnson, Janne Estill, Olivia Keiser, et al.
Plos One|January 13, 2012
Baseline predictors of sputum culture conversion in pulmonary tuberculosis: importance of cavities, smoking, time to detection and W-Beijing genotypeMarianne E Visser, Michael C Stead, Gerhard Walzl, et al.
Plos Medicine|November 8, 2017
Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort studySamantha R Kaplan, Christa Oosthuizen, Kathryn Stinson, et al.
Journal of the International AIDS Society|October 25, 2019
Feasibility of antiretroviral therapy initiation under the treat-all policy under routine conditions: a prospective cohort study from EswatiniBernhard Kerschberger, Kiran Jobanputra, Michael Schomaker, et al.
Journal of Epidemiology and Community Health|December 25, 2015
CD4 count at antiretroviral therapy initiation and the risk of loss to follow-up: results from a multicentre cohort studyAnna Grimsrud, Morna Cornell, Michael Schomaker, et al.
Pageof 8